Fluticasone-salmeterol 230-21 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26F5F4H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,266
Award facts
- Contract value 100% obligated
- $17,265.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,265.61 to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Fluticasone-Salmeterol 230-21 12GM pharmaceutical product, with ultimate completion scheduled for December 23, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement for delivery to the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that runs through December 2026 and serves as the comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a significant role in federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's federal contract awards with the Defense Logistics Agency demonstrate its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains in support of military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This delivery order for respiratory medication reflects the company's ongoing role as a critical vendor within the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F5F4H?
SPE2DR26F5F4H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F5F4H worth?
The government has obligated $17,266 on SPE2DR26F5F4H.
Is contract SPE2DR26F5F4H an order under another contract?
Yes. SPE2DR26F5F4H is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F4H competed?
The extent of competition for SPE2DR26F5F4H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award